AOA 2023: 12 new treatments optometrists should know about
Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.
AOA 2023: Surgical interventions should be considered earlier in glaucoma treatment
Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.
AOA 2023: Inside the top 5 myths of myopia management
Kevin Chan, OD, MS, FAAO, gives us an insider look at his AOA 2023 presentation, "Top 5 myths of myopia management and how to overcome them."
AOA 2023: Push for diversity, equity, and inclusion in optometry
Charissa Lee discusses diversity, equity, and inclusion within her role at Johnson & Johnson Vision and in the industry overall.
AOA 2023: Providing eye care for athletes
Graham Erickson, OD, FAAO, FCOVD, gives key takeaways of his presentation, "Sports vision grand rounds," which he presented during the 2023 AOA Optometry's Meeting in Washington, DC.
AOA 2023: Pharmaceutical treatment of anterior segment inflammatory conditions
Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.
AOA 2023: Taking a modern approach to dry eye
Jessilin Quint, OD, MBA, MS, FAAO, shares the latest and greatest in the world of dry eye, from new technology to how clinicians can start in on dry eye therapy today.
AOA 2023: Clinical study gives AMD patients possible new treatment
Jeffry Gerson, OD, FAAO, who presented a poster on the Light Site 3 clinical study at the AOA online e-poster event, discusses a promising new treatment for patients with AMD.
Meet the LEO founding board: Dr Howard Purcell
Howard Purcell, OD, FAAO, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).
AOA 2023: Practitioner assessment of fitting a novel silicone hydrogel daily disposable multifocal contact lens (ePoster)
Bill Reindel, OD, gives an overview of his e-poster, "Practitioner assessment of fitting a novel silicone hydrogel daily disposable multifocal contact lens," which he presented at AOA 2023.
ASCRS 2023 innovation highlights
Annual meeting places spotlight on newest clinical techniques, industry trends.
Meet the LEO founding board: Dr Karen Carrasquillo
Karen Carrasquillo, OD, PhD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).
FDA approves Novaliq's cyclosporine ophthalmic solution for treatment of signs and symptoms of dry eye disease
The water-free, preservative-free, anti-inflammatory drop from Novaliq, now coined Vevye, received FDA approval to treat the signs and symptoms of dry eye disease.
Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses
Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses leverage Bausch + Lomb’s proprietary lens tech to deliver all-day comfort and seamless transitions between near, intermediate, and distance vision for patients with presbyopia.
Dry Eye Foundation takes a stance on eye drop safety, encourages consumer education
Since April 2022, the Dry Eye Foundation has been voicing concerns over the packaging of preservative-free drops as well as availability of noncompliant drops at online retailers.
Q&A: What role do optometrists play in the treatment geographic atrophy?
Diagnose, monitor, comanage—optometrists support patients throughout all stages of the disease.
FDA approves Bausch + Lomb, Novaliq candidate NOV03 for signs and symptoms of dry eye disease
MIEBO, previously known as NOV03, is the first and only FDA-approved treatment for dry eye disease that targets tear evaporation.
Alimera nabs US commercial rights for Yutiq
Today, Alimera Sciences announced that they have acquired the US commercial rights of Yutiq (fluocinolone acetonide intravitreal insert) 0.18mg for the treatment of chronic non-infectious uveitis. Yutiq now joins Iluvien (fluocinolone acetonide intravitreal insert) 0.19 mg for DME in Alimera’s retina portfolio.
DR:EAM study: Exploring eye drops for diabetic retinopathy
The DR:EAM study in investigating novel eye drop OTT-166 for the treatment of diabetic retinopathy in hopes of reducing treatment burden for patients.
ASCRS 2023: Combination MIGs may reduce treatment burden for patients
Xiongfei Liu, MD, is presenting a talk entitled, "Effectiveness and safety of combining 2 MIGS devices in patients with open angle glaucoma," at ASCRS 2023 in San Diego, California.
ASCRS 2023: ViaLase to present clinical data, technology overview
The medical technology company ViaLase will reveal the 2-year data from their FLigHT clinical study as well as give additional information about their pipeline at ASCRS 2023.
Controversies in Modern Eye Care 2023: Dr Maloney shares his presentation sneak peek and what he's most excited about
Robert Maloney, MD, shares a sneak peek of his presentation and what he's looking forward to during the symposium.
Community care: Connecting mentorship and representation
Jill Saxon, OD, returns to Optometry Times On Air to discuss industry achievements, including the launch of the Women's Leadership Network and the Military Network at Bausch + Lomb.
FDA approves CT LUCIA 621P Monofocal IOL from Zeiss
The aspheric, monofocal, single-piece C-loop IOL from Zeiss compensates for a range of spherical aberrations to minimize decentration and lens misalignments.
IKA Keratoconus Symposium: Elevating scleral lens fittings
Jamie Kuzniar, OD, discusses scleral lens fitting for patients with keratoconus at the IKA Keratoconus Symposium in Scottsdale, Arizona.
ARVO 2023: SightGlass Vision presents positive outcomes for myopia spectacle lenses
Positive 42-month Cypress axial length and cSER outcomes, presented at ARVO in New Orleans, reinforce myopia control safety and efficacy of Diffusion Optics Technology™ spectacle lenses.
IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
IKA Keratoconus Symposium 2023: Strategies for early diagnosis
Today at the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.
IKA Keratoconus Symposium 2023: In-person white paper development, live patient Q&A
President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.
IKA Keratoconus Symposium 2023: Welcome to the inaugural event!
Co-founder of the International Keratoconus Academy S. Barry Eiden, OD, FAAO, FSLS, gives us the inside scoop on the inaugural IKA Keratoconus Symposium, which takes place this weekend in Scottsdale, Arizona.
2 Clarke Drive Cranbury, NJ 08512